A detailed history of Archer Investment Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Archer Investment Corp holds 11 shares of EXAS stock, worth $626. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Previous 3 266.67%
Holding current value
$626
Previous $169,000 181.66%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025

BUY
$43.04 - $58.51 $344 - $468
8 Added 266.67%
11 $476,000
Q3 2024

Nov 06, 2024

SELL
$42.43 - $70.83 $254 - $424
-6 Reduced 66.67%
3 $204,000
Q1 2024

May 09, 2024

BUY
$56.27 - $73.77 $168 - $221
3 Added 50.0%
9 $622,000
Q4 2023

Jan 30, 2024

BUY
$59.06 - $75.72 $354 - $454
6 New
6 $444,000
Q2 2021

Aug 05, 2021

SELL
$93.66 - $139.27 $1,873 - $2,785
-20 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $2,331 - $3,100
20 New
20 $2.64 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Archer Investment Corp Portfolio

Follow Archer Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Archer Investment Corp with notifications on news.